Titan Pharmaceuticals Inc. (NASDAQ: TTNP)
$4.76
+0.0900 ( +1.93% ) 2.0K
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Market Data
Open
$4.76
Previous close
$4.67
Volume
2.0K
Market cap
$4.47M
Day range
$4.51 - $5.29
52 week range
$4.24 - $13.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 46 | May 15, 2024 |
3 | Insider transactions | 1 | Apr 05, 2024 |
3 | Insider transactions | 1 | Apr 05, 2024 |
8-k | 8K-related | 17 | Apr 03, 2024 |
10-k | Annual reports | 74 | Apr 01, 2024 |
8-k | 8K-related | 13 | Apr 01, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
8-k | 8K-related | 13 | Mar 21, 2024 |
8-k | 8K-related | 14 | Feb 08, 2024 |
8-k | 8K-related | 12 | Jan 25, 2024 |